Financials
- Market Capitalization 4.57 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1376 | LEGN Legend Biotech Corporation - American Depositary Shares | 25.61 USD | -5.43% | -7.48% | -29.43% | -19.92% | 4.74 B USD | ||
| 1386 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 41.63 USD | -8.32% | +3.69% | +22.59% | +173.34% | 4.48 B USD | ||
| 1427 | VKTX Viking Therapeutics, Inc. - Common Stock | 37.78 USD | -2.78% | -1.82% | +32.56% | +22.78% | 4.39 B USD | ||
| 1436 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.46 USD | -2.90% | -1.43% | +18.53% | +21.64% | 4.36 B USD |
Frequently asked questions about Veracyte, Inc. - Common Stock
What is the Veracyte, Inc. - Common Stock stock price today?
The current price of Veracyte, Inc. - Common Stock (VCYT) is 57.25. Over the past 24 hours, the stock has changed by +0.49%. Follow the VCYT chart for real-time price dynamics.
What is the stock ticker of Veracyte, Inc. - Common Stock?
Veracyte, Inc. - Common Stock trades under the ticker VCYT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Veracyte, Inc. - Common Stock stock going up?
VCYT has changed by -1.78% over the last week, +20.50% over the last month, and +55.15% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Veracyte, Inc. - Common Stock net income for the last quarter?
Veracyte, Inc. - Common Stock reported net income of 28.71 M for the last quarter. The previous quarter showed 41.15 M, which means net income changed by -30.24%.
How many employees does Veracyte, Inc. - Common Stock have?
As of the latest available data, Veracyte, Inc. - Common Stock has 755 employees. Workforce size can provide additional context about the company's scale and operations.
What is Veracyte, Inc. - Common Stock EBITDA?
Veracyte, Inc. - Common Stock EBITDA is 65.99 M, and its EBITDA margin is 47.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Veracyte, Inc. - Common Stock stock?
You can buy Veracyte, Inc. - Common Stock (VCYT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Veracyte, Inc. - Common Stock stock?
Investing in Veracyte, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VCYT chart and related analysis on metatrader.com as part of your research.